| UniProt ID | S29A2_HUMAN | |
|---|---|---|
| UniProt AC | Q14542 | |
| Protein Name | Equilibrative nucleoside transporter 2 | |
| Gene Name | SLC29A2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 456 | |
| Subcellular Localization |
Basolateral cell membrane Multi-pass membrane protein . Nucleus membrane Multi-pass membrane protein . Localized at the basolateral cell membrane in polarized MDCK cells. |
|
| Protein Description | Mediates equilibrative transport of purine, pyrimidine nucleosides and the purine base hypoxanthine. Very less sensitive than SLC29A1 to inhibition by nitrobenzylthioinosine (NBMPR), dipyridamole, dilazep and draflazine.. | |
| Protein Sequence | MARGDAPRDSYHLVGISFFILGLGTLLPWNFFITAIPYFQARLAGAGNSTARILSTNHTGPEDAFNFNNWVTLLSQLPLLLFTLLNSFLYQCVPETVRILGSLLAILLLFALTAALVKVDMSPGPFFSITMASVCFINSFSAVLQGSLFGQLGTMPSTYSTLFLSGQGLAGIFAALAMLLSMASGVDAETSALGYFITPCVGILMSIVCYLSLPHLKFARYYLANKSSQAQAQELETKAELLQSDENGIPSSPQKVALTLDLDLEKEPESEPDEPQKPGKPSVFTVFQKIWLTALCLVLVFTVTLSVFPAITAMVTSSTSPGKWSQFFNPICCFLLFNIMDWLGRSLTSYFLWPDEDSRLLPLLVCLRFLFVPLFMLCHVPQRSRLPILFPQDAYFITFMLLFAVSNGYLVSLTMCLAPRQVLPHEREVAGALMTFFLALGLSCGASLSFLFKALL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 48 | N-linked_Glycosylation | ARLAGAGNSTARILS HHHCCCCCCCCEEEE | 35.34 | 12590919 | |
| 48 | N-linked_Glycosylation | ARLAGAGNSTARILS HHHCCCCCCCCEEEE | 35.34 | 12590919 | |
| 49 | Phosphorylation | RLAGAGNSTARILST HHCCCCCCCCEEEEC | 23.64 | 23312004 | |
| 50 | Phosphorylation | LAGAGNSTARILSTN HCCCCCCCCEEEECC | 24.77 | 23312004 | |
| 57 | N-linked_Glycosylation | TARILSTNHTGPEDA CCEEEECCCCCHHHC | 27.61 | 12590919 | |
| 57 | N-linked_Glycosylation | TARILSTNHTGPEDA CCEEEECCCCCHHHC | 27.61 | 12590919 | |
| 96 (in isoform 2) | Ubiquitination | - | 14.71 | 21906983 | |
| 108 (in isoform 2) | Ubiquitination | - | 2.78 | 21906983 | |
| 225 | N-linked_Glycosylation | FARYYLANKSSQAQA HHHHHHHCCCHHHHH | 41.99 | UniProtKB CARBOHYD | |
| 226 (in isoform 1) | Ubiquitination | - | 45.97 | 21906983 | |
| 226 | Ubiquitination | ARYYLANKSSQAQAQ HHHHHHCCCHHHHHH | 45.97 | 21906983 | |
| 226 (in isoform 3) | Ubiquitination | - | 45.97 | - | |
| 238 (in isoform 1) | Ubiquitination | - | 30.41 | 21906983 | |
| 238 (in isoform 3) | Ubiquitination | - | 30.41 | - | |
| 238 | Ubiquitination | QAQELETKAELLQSD HHHHHHHHHHHHHCC | 30.41 | 2190698 | |
| 244 | Phosphorylation | TKAELLQSDENGIPS HHHHHHHCCCCCCCC | 47.03 | 25159151 | |
| 251 | Phosphorylation | SDENGIPSSPQKVAL CCCCCCCCCCCEEEE | 53.37 | 30266825 | |
| 252 | Phosphorylation | DENGIPSSPQKVALT CCCCCCCCCCEEEEE | 26.46 | 30266825 | |
| 312 | Phosphorylation | LSVFPAITAMVTSST HHHHHHHHHHHHCCC | 15.71 | - | |
| 318 | Phosphorylation | ITAMVTSSTSPGKWS HHHHHHCCCCCCHHH | 24.44 | - | |
| 346 | Phosphorylation | IMDWLGRSLTSYFLW HHHHHCHHHHHHHCC | 33.91 | 26074081 | |
| 348 | Phosphorylation | DWLGRSLTSYFLWPD HHHCHHHHHHHCCCC | 23.72 | 26074081 | |
| 349 | Phosphorylation | WLGRSLTSYFLWPDE HHCHHHHHHHCCCCC | 21.12 | 26074081 | |
| 350 | Phosphorylation | LGRSLTSYFLWPDED HCHHHHHHHCCCCCC | 9.47 | 26074081 | |
| 358 | Phosphorylation | FLWPDEDSRLLPLLV HCCCCCCCCHHHHHH | 23.84 | 26074081 | |
| 395 | Phosphorylation | ILFPQDAYFITFMLL CCCCCHHHHHHHHHH | 12.10 | - | |
| 409 | Phosphorylation | LFAVSNGYLVSLTMC HHHHHCCCHHEEEEE | 14.26 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of S29A2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of S29A2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of S29A2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| UBQL1_HUMAN | UBQLN1 | physical | 25416956 |
| Kegg Disease | |
|---|---|
| There are no disease associations of PTM sites. | |
| OMIM Disease | |
| There are no disease associations of PTM sites. | |
| Kegg Drug | |
| D04931 | Mercaptopurine (INN); Mercaptopurine anhydrous; Purinethol (TN) |
| DrugBank | |
| DB00900 | Didanosine |
| DB00898 | Ethanol |
| DB00441 | Gemcitabine |
| DB01033 | Mercaptopurine |
| DB00943 | Zalcitabine |
| DB00495 | Zidovudine |
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Functional analysis of site-directed glycosylation mutants of thehuman equilibrative nucleoside transporter-2."; Ward J.L., Leung G.P., Toan S.V., Tse C.-M.; Arch. Biochem. Biophys. 411:19-26(2003). Cited for: GLYCOSYLATION AT ASN-48 AND ASN-57. | |
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-252, AND MASSSPECTROMETRY. | |